Propylene glycol-induced side effects during intravenous nitroglycerin therapy
Authors:
- 1 May 1988
- journal article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 14 (3) , 221-226
Abstract
Propylene glycol, an alcohol frequently used as a solvent in medical preparations, is considered non-toxic. We found that this solvent, used in a commercially available IV nitroglycerin solution, may cause hyperosmolality, hemolysis and lactic acidosis. The influence of kidney function as the main determinant in causing accumulation of this solvent and consequently hyperosmolality is emphasized. A review of the literature dealing with propylene glycol is given. The possible mechanisms of neurological disturbances occurring during IV nitroglycerin therapy are discussed.Keywords
This publication has 37 references indexed in Scilit:
- Intravenous nitroglycerin-induced intracranial hypertensionCritical Care Medicine, 1985
- Pharmacokinetics of Propylene Glycol in Humans During Multiple Dosing RegimensJournal of Pharmaceutical Sciences, 1985
- Propylene glycol-induced heparin resistance during nitroglycerin infusionAmerican Heart Journal, 1985
- Serum OsmolalityNew England Journal of Medicine, 1984
- TRIAL OF HEPARIN VERSUS ATENOLOL IN PREVENTION OF MYOCARDIAL INFARCTION IN INTERMEDIATE CORONARY SYNDROMEThe Lancet, 1981
- Propylene Glycol Intoxication and Lactic AcidosisNew England Journal of Medicine, 1980
- Intracranial Hypertension Caused by NitroglycerinAnesthesiology, 1979
- Central nervous system toxicity associated with ingestion of propylene glycolThe Journal of Pediatrics, 1978
- Propylene glycol: A potentially toxic vehicle in liquid dosage formThe Journal of Pediatrics, 1970
- Acute and Subacute Coronary InsufficiencyBMJ, 1961